US Patent Issued to GenMont Biotech Incorporation on March 17 for "Application based nucleotides of Lactobacillus rhamnosus to prepare a composition for anti-lipogenesis" (Taiwanese Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,101, issued on March 17, was assigned to GenMont Biotech Incorporation (Tainan City, Taiwan).

"Application based nucleotides of Lactobacillus rhamnosus to prepare a composition for anti-lipogenesis" was invented by Wan-Hua Tsai (Kaohsiung City, Taiwan), Yi-Ting Fang (Tainan City, Taiwan), Chia-Yu Chang (Tainan City, Taiwan) and Hsueh-Te Lee (Kaohsiung City, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "An application based on nucleotide fragments of Lactobacillus rhamnosus GM-020, to prepare a composition for anti-lipogenesis. The Lactobacillus rhamnosus GM-020 was deposited on Dec. 18, 2003 and has the CCTCC designation number CCTCC M20309...